ID   KCND3_RAT               Reviewed;         655 AA.
AC   Q62897; O08723; P70622; Q63286; Q99P42;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   07-NOV-2003, sequence version 2.
DT   02-OCT-2024, entry version 186.
DE   RecName: Full=A-type voltage-gated potassium channel KCND3 {ECO:0000305};
DE   AltName: Full=Potassium voltage-gated channel subfamily D member 3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv4.3;
GN   Name=Kcnd3 {ECO:0000312|RGD:68394};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TRANSPORTER ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=8831489; DOI=10.1161/01.res.79.4.659;
RA   Dixon J.E., Shi W., Wang H.-S., McDonald C., Yu H., Wymore R.S.,
RA   Cohen I.S., McKinnon D.;
RT   "Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate
RT   for the transient outward current.";
RL   Circ. Res. 79:659-668(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TRANSPORTER ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=8734615; DOI=10.1152/jn.1996.75.5.2174;
RA   Serodio P., Vega-Saenz de Miera E., Rudy B.;
RT   "Cloning of a novel component of A-type K+ channels operating at
RT   subthreshold potentials with unique expression in heart and brain.";
RL   J. Neurophysiol. 75:2174-2179(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, TRANSPORTER ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Hippocampus;
RX   PubMed=9001401; DOI=10.1016/s0014-5793(96)01388-9;
RA   Tsaur M.-L., Chou C.-C., Shih Y.-H., Wang H.-L.;
RT   "Cloning, expression and CNS distribution of Kv4.3, an A-type K+ channel
RT   alpha subunit.";
RL   FEBS Lett. 400:215-220(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TRANSPORTER ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Smooth muscle, and Vas deferens;
RX   PubMed=9450548; DOI=10.1016/s0014-5793(97)01483-x;
RA   Ohya S., Tanaka M., Oku T., Asai Y., Watanabe M., Giles W.R., Imaizumi Y.;
RT   "Molecular cloning and tissue distribution of an alternatively spliced
RT   variant of an A-type K+ channel alpha-subunit, Kv4.3 in the rat.";
RL   FEBS Lett. 420:47-53(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Uterus;
RX   PubMed=11427525; DOI=10.1074/jbc.m101058200;
RA   Song M., Helguera G., Eghbali M., Zhu N., Zarei M.M., Olcese R., Toro L.,
RA   Stefani E.;
RT   "Remodeling of Kv4.3 potassium channel gene expression under the control of
RT   sex hormones.";
RL   J. Biol. Chem. 276:31883-31890(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 455-606 (ISOFORM 1).
RC   STRAIN=Sprague-Dawley;
RX   PubMed=9314834; DOI=10.1161/01.res.81.4.533;
RA   Takimoto K., Li D., Hershman K.M., Li P., Jackson E.K., Levitan E.S.;
RT   "Decreased expression of Kv4.2 and novel Kv4.3 K+ channel subunit mRNAs in
RT   ventricles of renovascular hypertensive rats.";
RL   Circ. Res. 81:533-539(1997).
RN   [7]
RP   INTERACTION WITH KCNIP1; KCNIP2 AND KCNIP3.
RX   PubMed=10676964; DOI=10.1038/35000592;
RA   An W.F., Bowlby M.R., Betty M., Cao J., Ling H.-P., Mendoza G.,
RA   Hinson J.W., Mattsson K.I., Strassle B.W., Trimmer J.S., Rhodes K.J.;
RT   "Modulation of A-type potassium channels by a family of calcium sensors.";
RL   Nature 403:553-556(2000).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12006572; DOI=10.1074/jbc.m203651200;
RA   Takimoto K., Yang E.-K., Conforti L.;
RT   "Palmitoylation of KChIP splicing variants is required for efficient cell
RT   surface expression of Kv4.3 channels.";
RL   J. Biol. Chem. 277:26904-26911(2002).
RN   [9]
RP   INTERACTION WITH KCNIP4.
RX   PubMed=11805342; DOI=10.1073/pnas.022509299;
RA   Holmqvist M.H., Cao J., Hernandez-Pineda R., Jacobson M.D., Carroll K.I.,
RA   Sung M.A., Betty M., Ge P., Gilbride K.J., Brown M.E., Jurman M.E.,
RA   Lawson D., Silos-Santiago I., Xie Y., Covarrubias M., Rhodes K.J.,
RA   Distefano P.S., An W.F.;
RT   "Elimination of fast inactivation in Kv4 A-type potassium channels by an
RT   auxiliary subunit domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:1035-1040(2002).
RN   [10]
RP   PHOSPHORYLATION AT SER-569 BY CAMK2D.
RX   PubMed=15456698; DOI=10.1152/ajpcell.00293.2004;
RA   Sergeant G.P., Ohya S., Reihill J.A., Perrino B.A., Amberg G.C.,
RA   Imaizumi Y., Horowitz B., Sanders K.M., Koh S.D.;
RT   "Regulation of Kv4.3 currents by Ca2+/calmodulin-dependent protein kinase
RT   II.";
RL   Am. J. Physiol. 288:C304-C313(2005).
RN   [11] {ECO:0000305}
RP   INTERACTION WITH DLG1, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=19213956; DOI=10.1161/circresaha.108.191007;
RA   El-Haou S., Balse E., Neyroud N., Dilanian G., Gavillet B., Abriel H.,
RA   Coulombe A., Jeromin A., Hatem S.N.;
RT   "Kv4 potassium channels form a tripartite complex with the anchoring
RT   protein SAP97 and CaMKII in cardiac myocytes.";
RL   Circ. Res. 104:758-769(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [13] {ECO:0007744|PDB:2I2R}
RP   X-RAY CRYSTALLOGRAPHY (3.35 ANGSTROMS) OF 2-143 IN COMPLEX WITH KCNIP1 AND
RP   ZN(2+), FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=17057713; DOI=10.1038/nsmb1164;
RA   Pioletti M., Findeisen F., Hura G.L., Minor D.L. Jr.;
RT   "Three-dimensional structure of the KChIP1-Kv4.3 T1 complex reveals a
RT   cross-shaped octamer.";
RL   Nat. Struct. Mol. Biol. 13:987-995(2006).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated A-type
CC       potassium channels that mediates transmembrane potassium transport in
CC       excitable membranes, in brain and heart (PubMed:17057713,
CC       PubMed:8734615, PubMed:8831489, PubMed:9001401, PubMed:9450548). In
CC       cardiomyocytes, may generate the transient outward potassium current
CC       I(To) (Probable). In neurons, may conduct the transient subthreshold
CC       somatodendritic A-type potassium current (ISA) (Probable). Kinetics
CC       properties are characterized by fast activation at subthreshold
CC       membrane potentials, rapid inactivation, and quick recovery from
CC       inactivation (PubMed:17057713, PubMed:8734615, PubMed:8831489,
CC       PubMed:9001401, PubMed:9450548). Channel properties are modulated by
CC       interactions with regulatory subunits (PubMed:10676964,
CC       PubMed:17057713). Interaction with the regulatory subunits KCNIP1 or
CC       KCNIP2 modulates the channel gating kinetics namely channel activation
CC       and inactivation kinetics and rate of recovery from inactivation
CC       (PubMed:10676964, PubMed:17057713). Likewise, interaction with DPP6
CC       modulates the channel gating kinetics namely channel activation and
CC       inactivation kinetics (By similarity). {ECO:0000250|UniProtKB:Q9UK17,
CC       ECO:0000269|PubMed:10676964, ECO:0000269|PubMed:17057713,
CC       ECO:0000269|PubMed:8734615, ECO:0000269|PubMed:8831489,
CC       ECO:0000269|PubMed:9001401, ECO:0000269|PubMed:9450548,
CC       ECO:0000305|PubMed:8734615, ECO:0000305|PubMed:8831489}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:17057713, ECO:0000269|PubMed:8734615,
CC         ECO:0000269|PubMed:8831489, ECO:0000269|PubMed:9001401,
CC         ECO:0000269|PubMed:9450548};
CC   -!- SUBUNIT: Homotetramer (By similarity). Heterotetramer with KCND2 (By
CC       similarity). Associates with the regulatory subunits KCNIP3 and KCNIP4
CC       (PubMed:10676964, PubMed:11805342). Interacts with KCNE1, KCNE2, SCN1B
CC       and KCNAB1 and DLG1 (By similarity). Component of heteromultimeric
CC       potassium channels. Identified in potassium channel complexes
CC       containing KCND1, KCND2, KCND3, KCNIP1, KCNIP2, KCNIP3, KCNIP4, DPP6
CC       and DPP10 (By similarity). Interacts with KCNIP1; each KCNIP1 monomer
CC       interacts with two adjacent KCND3 subunits, through both the N-terminal
CC       inactivation ball of a KCND3 subunit and a C-terminal helix from the
CC       adjacent KCND3 subunit, clamping them together; this interaction
CC       stabilizes the tetrameric form and modulates the channel gating
CC       kinetics namely channel activation and inactivation kinetics and rate
CC       of recovery from inactivation (PubMed:10676964, PubMed:17057713).
CC       Interacts with DPP6; this interaction modulates the channel gating
CC       kinetics namely channel activation and inactivation kinetics and rate
CC       of recovery from inactivation (By similarity). Interacts with KCNIP2;
CC       each KCNIP2 monomer interacts with two adjacent KCND3 subunits, through
CC       both the N-terminal inactivation ball of a KCND3 subunit and a C-
CC       terminal helix from the adjacent KCND3 subunit, clamping them together;
CC       this interaction modulates the channel gating kinetics
CC       (PubMed:10676964). {ECO:0000250|UniProtKB:Q9UK17,
CC       ECO:0000250|UniProtKB:Q9Z0V1, ECO:0000269|PubMed:10676964,
CC       ECO:0000269|PubMed:11805342, ECO:0000269|PubMed:17057713}.
CC   -!- INTERACTION:
CC       Q62897; Q9NZI2: KCNIP1; Xeno; NbExp=3; IntAct=EBI-7082853, EBI-2120635;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12006572,
CC       ECO:0000269|PubMed:19213956}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell membrane, sarcolemma {ECO:0000269|PubMed:19213956};
CC       Multi-pass membrane protein {ECO:0000255}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:19213956}. Note=Interaction with palmitoylated
CC       KCNIP2 and KCNIP3 enhances cell surface expression.
CC       {ECO:0000269|PubMed:12006572}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Kv4.3 long form;
CC         IsoId=Q62897-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q62897-2; Sequence=VSP_008831;
CC       Name=3;
CC         IsoId=Q62897-3; Sequence=VSP_008831, VSP_008832;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, in particular in the
CC       retrosplenial cortex, medial habenula, anterior thalamus, hippocampus,
CC       cerebellum and lateral geniculate and superior colliculus
CC       (PubMed:8734615, PubMed:9001401, PubMed:9450548). Highly expressed in
CC       heart atrium (at protein level) and throughout the ventricle wall, in
CC       lung and vas deferens (PubMed:8734615, PubMed:8831489, PubMed:9450548).
CC       {ECO:0000269|PubMed:19213956, ECO:0000269|PubMed:8734615,
CC       ECO:0000269|PubMed:8831489, ECO:0000269|PubMed:9001401,
CC       ECO:0000269|PubMed:9450548}.
CC   -!- DOMAIN: Two N-terminal domains regulate binding to and modulation by
CC       KCNIP1. {ECO:0000250|UniProtKB:Q9UK17}.
CC   -!- PTM: Regulated through phosphorylation at Ser-569 by CaMK2D.
CC       {ECO:0000269|PubMed:15456698}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. D (Shal) (TC
CC       1.A.1.2) subfamily. Kv4.3/KCND3 sub-subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U75448; AAB18337.1; -; mRNA.
DR   EMBL; U42975; AAC52695.1; -; mRNA.
DR   EMBL; L48619; AAA80459.1; -; mRNA.
DR   EMBL; AB003587; BAA24525.1; -; mRNA.
DR   EMBL; AF334791; AAK07651.1; -; mRNA.
DR   EMBL; U92897; AAB53321.1; -; mRNA.
DR   RefSeq; NP_001257891.1; NM_001270962.1.
DR   RefSeq; NP_001257892.1; NM_001270963.1.
DR   RefSeq; NP_113927.2; NM_031739.3. [Q62897-3]
DR   PDB; 2I2R; X-ray; 3.35 A; A/B/C/D/I/J/K/L=2-143.
DR   PDBsum; 2I2R; -.
DR   AlphaFoldDB; Q62897; -.
DR   SMR; Q62897; -.
DR   BioGRID; 249307; 1.
DR   CORUM; Q62897; -.
DR   DIP; DIP-29245N; -.
DR   IntAct; Q62897; 2.
DR   MINT; Q62897; -.
DR   STRING; 10116.ENSRNOP00000019997; -.
DR   ChEMBL; CHEMBL5169162; -.
DR   DrugCentral; Q62897; -.
DR   GuidetoPHARMACOLOGY; 554; -.
DR   iPTMnet; Q62897; -.
DR   PhosphoSitePlus; Q62897; -.
DR   PaxDb; 10116-ENSRNOP00000019997; -.
DR   ABCD; Q62897; 2 sequenced antibodies.
DR   GeneID; 65195; -.
DR   KEGG; rno:65195; -.
DR   UCSC; RGD:68394; rat. [Q62897-1]
DR   AGR; RGD:68394; -.
DR   CTD; 3752; -.
DR   RGD; 68394; Kcnd3.
DR   eggNOG; KOG4390; Eukaryota.
DR   InParanoid; Q62897; -.
DR   OrthoDB; 1478695at2759; -.
DR   PhylomeDB; Q62897; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-RNO-1296072; Voltage gated Potassium channels.
DR   Reactome; R-RNO-5576894; Phase 1 - inactivation of fast Na+ channels.
DR   EvolutionaryTrace; Q62897; -.
DR   PRO; PR:Q62897; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000014686; Expressed in Ammon's horn and 14 other cell types or tissues.
DR   ExpressionAtlas; Q62897; baseline and differential.
DR   GO; GO:0005901; C:caveola; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IBA:GO_Central.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0097038; C:perinuclear endoplasmic reticulum; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IBA:GO_Central.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; ISO:RGD.
DR   GO; GO:0034705; C:potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005250; F:A-type (transient outward) potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005216; F:monoatomic ion channel activity; IDA:RGD.
DR   GO; GO:0005267; F:potassium channel activity; IDA:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; ISO:RGD.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:CAFA.
DR   GO; GO:0001508; P:action potential; IBA:GO_Central.
DR   GO; GO:0071773; P:cellular response to BMP stimulus; IMP:RGD.
DR   GO; GO:0086009; P:membrane repolarization; ISO:RGD.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; IEA:GOC.
DR   GO; GO:0097623; P:potassium ion export across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IDA:CAFA.
DR   GO; GO:0006813; P:potassium ion transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; ISO:RGD.
DR   GO; GO:0099625; P:ventricular cardiac muscle cell membrane repolarization; ISO:RGD.
DR   CDD; cd18419; BTB_POZ_KCND3; 1.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003975; K_chnl_volt-dep_Kv4.
DR   InterPro; IPR004056; K_chnl_volt-dep_Kv4.3.
DR   InterPro; IPR024587; K_chnl_volt-dep_Kv4_C.
DR   InterPro; IPR021645; Shal-type_N.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR11537:SF182; POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY D MEMBER 3; 1.
DR   PANTHER; PTHR11537; VOLTAGE-GATED POTASSIUM CHANNEL; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF11879; DUF3399; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11601; Shal-type; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01518; KV43CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01497; SHALCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; POZ domain; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cell projection;
KW   Ion channel; Ion transport; Membrane; Metal-binding; Phosphoprotein;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel; Zinc.
FT   CHAIN           1..655
FT                   /note="A-type voltage-gated potassium channel KCND3"
FT                   /id="PRO_0000054071"
FT   TOPO_DOM        1..182
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   TRANSMEM        183..204
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   TOPO_DOM        205..223
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   TRANSMEM        224..246
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   TOPO_DOM        247..253
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   TRANSMEM        254..277
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   TOPO_DOM        278..283
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   TRANSMEM        284..306
FT                   /note="Helical; Voltage-sensor; Name=Segment S4"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   TOPO_DOM        307..318
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   TRANSMEM        319..343
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   TOPO_DOM        344..352
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   INTRAMEM        353..366
FT                   /note="Helical; Name=Pore helix"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   INTRAMEM        367..374
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TRANSMEM        378..400
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   TOPO_DOM        401..655
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   REGION          6..21
FT                   /note="Interaction with KCNIP1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   REGION          70..78
FT                   /note="Interaction with KCNIP1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   REGION          470..487
FT                   /note="Interaction with KCNIP1 and KCNIP2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UK17"
FT   REGION          474..489
FT                   /note="Mediates dendritic targeting"
FT                   /evidence="ECO:0000250|UniProtKB:Q63881"
FT   REGION          523..565
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          616..647
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           367..372
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   COMPBIAS        624..639
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         104
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homodimeric partners"
FT                   /note="in chain B"
FT                   /evidence="ECO:0000269|PubMed:17057713,
FT                   ECO:0007744|PDB:2I2R"
FT   BINDING         110
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homodimeric partners"
FT                   /note="in chain D"
FT                   /evidence="ECO:0000269|PubMed:17057713,
FT                   ECO:0007744|PDB:2I2R"
FT   BINDING         131
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homodimeric partners"
FT                   /note="in chain B"
FT                   /evidence="ECO:0000269|PubMed:17057713,
FT                   ECO:0007744|PDB:2I2R"
FT   BINDING         132
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homodimeric partners"
FT                   /note="in chain B"
FT                   /evidence="ECO:0000269|PubMed:17057713,
FT                   ECO:0007744|PDB:2I2R"
FT   BINDING         367
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   BINDING         368
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   BINDING         369
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   BINDING         370
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   MOD_RES         153
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         459
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0V1"
FT   MOD_RES         569
FT                   /note="Phosphoserine; by CaMK2D"
FT                   /evidence="ECO:0000269|PubMed:15456698"
FT   MOD_RES         585
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0V1"
FT   VAR_SEQ         488..506
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:8734615,
FT                   ECO:0000303|PubMed:8831489, ECO:0000303|PubMed:9001401"
FT                   /id="VSP_008831"
FT   VAR_SEQ         608..655
FT                   /note="SQITTAIISIPTPPALTPEGESRPPPASPGPNTNIPSITSNVVKVSVL ->
FT                   QDQEQPRGRVVTCKQEEIITLCI (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9001401"
FT                   /id="VSP_008832"
FT   CONFLICT        124
FT                   /note="L -> H (in Ref. 3; AAA80459)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        404
FT                   /note="S -> T (in Ref. 2; AAC52695 and 5; AAK07651)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        569
FT                   /note="S -> T (in Ref. 3; AAA80459)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        631
FT                   /note="P -> A (in Ref. 2; AAC52695)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        654
FT                   /note="V -> A (in Ref. 1; AAB18337 and 4; BAA24525)"
FT                   /evidence="ECO:0000305"
FT   TURN            6..8
FT                   /evidence="ECO:0007829|PDB:2I2R"
FT   HELIX           9..16
FT                   /evidence="ECO:0007829|PDB:2I2R"
FT   STRAND          41..46
FT                   /evidence="ECO:0007829|PDB:2I2R"
FT   STRAND          49..54
FT                   /evidence="ECO:0007829|PDB:2I2R"
FT   HELIX           55..59
FT                   /evidence="ECO:0007829|PDB:2I2R"
FT   TURN            65..67
FT                   /evidence="ECO:0007829|PDB:2I2R"
FT   HELIX           70..74
FT                   /evidence="ECO:0007829|PDB:2I2R"
FT   TURN            77..80
FT                   /evidence="ECO:0007829|PDB:2I2R"
FT   STRAND          81..84
FT                   /evidence="ECO:0007829|PDB:2I2R"
FT   HELIX           88..99
FT                   /evidence="ECO:0007829|PDB:2I2R"
FT   HELIX           111..121
FT                   /evidence="ECO:0007829|PDB:2I2R"
FT   TURN            130..132
FT                   /evidence="ECO:0007829|PDB:2I2R"
FT   HELIX           133..138
FT                   /evidence="ECO:0007829|PDB:2I2R"
SQ   SEQUENCE   655 AA;  73513 MW;  26BC512BDE069C09 CRC64;
     MAAGVAAWLP FARAAAIGWM PVANCPMPLA PADKNKRQDE LIVLNVSGRR FQTWRTTLER
     YPDTLLGSTE KEFFFNEDTK EYFFDRDPEV FRCVLNFYRT GKLHYPRYEC ISAYDDELAF
     YGILPEIIGD CCYEEYKDRK RENAERLMDD NESENNQESM PSLSFRQTMW RAFENPHTST
     LALVFYYVTG FFIAVSVITN VVETVPCGTV PGSKELPCGE RYSVAFFCLD TACVMIFTVE
     YLLRLFAAPS RYRFIRSVMS IIDVVAIMPY YIGLVMTNNE DVSGAFVTLR VFRVFRIFKF
     SRHSQGLRIL GYTLKSCASE LGFLLFSLTM AIIIFATVMF YAEKGSSASK FTSIPASFWY
     TIVTMTTLGY GDMVPKTIAG KIFGSICSLS GVLVIALPVP VIVSNFSRIY HQNQRADKRR
     AQKKARLARI RVAKTGSSNA YLHSKRNGLL NEALELTGTP EEEHMGKTTS LIESQHHHLL
     HCLEKTTGLS YLVDDPLLSV RTSTIKNHEF IDEQMFEQNC MESSMQNYPS TRSPSLSSHS
     GLTTTCCSRR SKKTTHLPNS NLPATRLRSM QELSTIHIQG SEQPSLTTSR SSLNLKADDG
     LRPNCKTSQI TTAIISIPTP PALTPEGESR PPPASPGPNT NIPSITSNVV KVSVL
//
